comparemela.com
Home
Live Updates
DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD : comparemela.com
DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD
/PRNewswire/ -- DP Technology, an "AI for Science" new paradigm-driven company, today announced the nomination of DPT0218, a novel small molecule targeting Kv1....
Related Keywords
Beijing
,
China
,
Xiaomin Zhang
,
Anna Lena Unterweger
,
Fabrizio Giordanetto
,
Johnt Chang
,
Eli Lilly
,
Weijie Sun
,
Prnewswire Dp Technology
,
Company Lilly
,
Dp Technology
,
De Shaw Research
,
Source Dp Technology
,
Inflammatory Bowel Disease
,
Atopic Dermatitis
,
Shaw Research
,
Drug Discovery
,
Reinforced Dynamics
,
Artificial Intelligence
,
Molecular Simulation
,
Exp Med
,
Englj Med
,
Inflammatory Bowel
,
Lena Unterweger
,
Channel Activity
,
Humanised Mouse Model
,
comparemela.com © 2020. All Rights Reserved.